Some Patients With COVID-19 Who Do Not Receive Treatment With Nirmatrelvir-Ritonavir Still Experience Rebound In Symptoms, Study Shows

October 28, 2022

The New York Times (10/27, Sheikh) reports a study “found that when patients” with COVID-19 “received a placebo instead of treatment” with nirmatrelvir-ritonavir (Paxlovid), “a portion of them still experienced a rebound of their symptoms after they had i...